NAPLEX Study Guide retweeted
Happy Fourth of July!
Here's to 250 years of independence and a weekend filled with celebration, sunshine, and time with loved ones.
Wishing everyone a safe and happy holiday!
NAPLEX Study Guide retweeted
🚨 An FDA advisory panel has unanimously backed Moderna’s investigational mRNA flu vaccine.
If approved, it could mark a major expansion of mRNA technology beyond COVID-19 and help shape the future of influenza prevention.
🔗 pharmacytimes.com/view/fda-p…
#mRNA #Influenza #Vaccines #FDA #PublicHealth #PharmacyTimes #MedicalResearch
NAPLEX Study Guide retweeted
A new meta-analysis concludes that Nissen fundoplication provides durable GERD relief, although gas bloating and dysphagia are common, and one quarter of patients resume PPIs. Read the key results: nej.md/4uDNffK
#Gastroenterology

ALT The image shows a Journal Watch headline "Long-Term Outcomes of Laparoscopic Nissen Fundoplication." Authors Sharmeel Kaur Wasan, M.D. and Christopher W. Goodman, M.D. are mentioned, with the article reviewed in "Annals of Surgery." The NEJM Clinician logo is displayed in the lower right. The background is a green and blue gradient.
NAPLEX Study Guide retweeted
As endometrial cancer cases continue to rise, so does the need for earlier recognition, equitable care, and informed treatment decision-making.
Megan May, PharmD, BCOP, FHOPA, FAPO, Jennifer MacDonald, PharmD, BCOP, Erin Zacholski, PharmD, BCOP, and Justina Salib, PharmD, BCOP, discuss the growing clinical and economic burden of endometrial cancer, including the increasing prevalence of aggressive histologic subtypes, and the importance of screening and clinical trial enrollment to improve patient outcomes.
This conversation sets the stage for the evolving treatment landscape and the role pharmacists continue to play in supporting timely, evidence-based care.
Watch the clip below, then follow along with the full Peer Exchange series for more expert insights into the future of endometrial cancer management: hubs.li/Q04hmm2l0
NAPLEX Study Guide retweeted
🚨 BREAKING: Retatrutide shows “bariatric-level” weight loss in Phase 3 TRIUMPH-1 trial.
New data suggest one of the strongest weight-loss effects seen yet from a GLP-1–based therapy class.
🔗 pharmacytimes.com/view/retat…
#GLP1 #Obesity #ClinicalTrials #PharmacyTimes #WeightLoss #Healthcare
FDA Approves Langlara (insulin glargine-aldy), an Interchangeable Biosimilar to Lantus drugs.com/newdrugs/fda-appro…
Gabapentinoids like gabapentin and pregabalin are associated with an increased risk for poisoning, with the highest risk occurring around treatment initiation and when combined with benzodiazepines or opioids.
In a large UK study of nearly 17,000 primary care patients, those who had co-initiation of gabapentinoids and benzodiazepines showed double the risk for hospitalization due to drug poisoning within the first month, whereas those with concomitant opioid use showed a 30% increased risk compared with those who took neither medication. mdsc.pe/4w6yUdZ
Dupixent Patient Tips: 7 Things you Should Know drugs.com/tips/dupixent-pati…
NAPLEX Study Guide retweeted
NSAIDS - Key Details (1/6)
Pharmacy technicians are required to have an extensive understanding of NSAIDs; a class of medicines widely used in the management of pain, fever, and inflammation.
Here, we've put together all the key facts that technicians need to know, covering:
☑ Indications
☑ Key examples
☑ Side effects / warnings
☑ Mechanism of action
☑ Interactions
FDA Approves Idvynso (doravirine and islatravir) for the Treatment of HIV-1 Infection in Adults drugs.com/newdrugs/fda-appro…
Epinephrine is widely used during cardiac arrest because it increases vascular tone, blood pressure, and heart rate, improving the likelihood of return of spontaneous circulation (ROSC).
Yet its role remains contested. Evidence from the PARAMEDIC2 trial and later analyses showed that although epinephrine improves ROSC rates, it does not lead to better neurologic recovery and may adversely affect cerebral microcirculation while promoting platelet aggregation. These findings have sharpened clinical and ethical debate over whether improved short-term survival justifies potential harm to neurologic outcomes. mdsc.pe/4tY3i99
Repatha Patient Tips: 7 Things You should Know drugs.com/tips/repatha-patie…
FDA Approves Labeling Changes to Six Menopausal Hormone Therapy Products drugs.com/fda/fda-approves-l…
FDA Approves Combination Yuvezzi Eye Drop for Presbyopia in Adults drugs.com/news/fda-approves-…
NAPLEX Study Guide retweeted
#FDA grants orphan drug designation to zavabresib for myelofibrosis, supporting development of this potential treatment for a serious disease with significant unmet needs and limited options. #medTwitter
Read more here: hubs.li/Q041yJpw0
Study Finds Genetics May Shape Up to 55% of How Long You Live drugs.com/news/study-finds-g…




















